| ACCs | articular cartilage chondrocytes |
| ACI | autologous chondrocyte implantation |
| ACLT | anterior cruciate ligament transection |
| AD-MSCs | adipose-derived mesenchymal stem cells |
| AGEs | advanced glycation end-products |
| AGG | aggrecan |
| antimiR-221 | microRNA inhibitor targeting miR-221 |
| ApoPep-1 | apoptosis-targeting peptide-1 |
| BGP | β-glycerophosphate |
| BM-MSCs | bone marrow-derived mesenchymal stromal cells |
| BMP | bone morphogenetic protein |
| C-ACT | collagen-augmented chondrogenesis technique |
| CCP | costal chondrocyte-derived pellet-type |
| Col-1 | collagen type I |
| Col-2 | collagen type II |
| CPCs | chondrogenic progenitor cells |
| CS-MA | methacrylated chondroitin sulfate |
| ECM | extracellular matrix |
| EPL | ε-poly-L-lysine |
| GAG | glycosaminoglycan |
| GelMA | gelatin–methacrylamide |
| GO | graphene oxide |
| HA | hyaluronic acid |
| haMPCs | human adipose-derived mesenchymal progenitor cells |
| hAMSCs | human amniotic mesenchymal stem cells |
| HAV | histidine-alanine-valine |
| hMSCs | human mesenchymal stem cells |
| HTO | high tibial osteotomy |
| hWJ-MSC-Exos | hWJ-MSC-derived exosomes |
| hWJ-MSC | human Wharton’s Jelly mesenchymal stem cells |
| ICRS | International Cartilage Repair Society |
| IGF-1 | insulin-like growth factor-1 |
| IPFP | infrapatellar fat pad |
| JS-Paint | joint surface paint |
| KGN | kartogenin |
| KL Grade | Kellgren and Lawrence Grade |
| LAA | L-ascorbic acid |
| MACI | matrix-induced autologous chondrocyte implantation |
| MAP | microporous annealed particle |
| MeHA | methacrylated hyaluronic acid |
| MMPs | matrix metalloproteinases |
| MRI | magnetic resonance imaging |
| MSC-Exos | MSC-derived exosomes |
| MSCs | mesenchymal stem cells |
| NB | N-(2-aminoethyl)-4-(4-(hydroxymethyl)-2-methoxy-5-nitrosophenoxy) butanamide |
| NOD/SCID | non-obese diabetic/severe combined immunodeficient |
| OA | Osteoarthritis |
| OLT | osteochondral lesion of the talus |
| OPF | oligo(poly(ethylene glycol) fumarate) |
| PCL | poly(ε-caprolactone) |
| PCM | pericellular matrix |
| PD sheets | allogeneic polydactyly-derived chondrocyte sheets |
| PDLLA | poly-D, L-lactic acid/polyethylene glycol |
| PEG | polyethylene glycol |
| PL | platelet lysate |
| PLA | polylactic acid |
| PLEL | poly(d,L-lactide)-poly(ethylene glycol)-poly(d,L-lactide) |
| PLGA | poly(lactic-co-glycolic acid) |
| PMPC | poly(2-methacryloyloxyethyl phosphorylcholine) |
| PRP | platelet-rich plasma |
| PTOA | post-traumatic osteoarthritis |
| RAGE | receptor for advanced glycation endproducts |
| RCTs | randomized clinical trials |
| RGD | arginine-glycine-aspartate |
| rhSDF-1α | recombinant human stromal cell–derived factor 1α |
| rhTG-4 | recombinant human transglutaminase 4 |
| ROS | reactive oxygen species |
| SASP | senescence-associated secretory phenotype |
| SDF-1 | stromal cell-derived factor-1 |
| SDS | sodium dodecyl sulfate |
| SF-MSCs | synovial fluid-derived mesenchymal stem cells |
| SF | silk fibroin |
| Si-HPMC | siloxane derived hydroxypropylmethylcellulose |
| SMSCs | synovium-derived mesenchymal stem cells |
| SS | silk spidroin |
| SVF | stromal vascular fraction |
| TAN | tanshinone IIA |
| TCO | trans-cyclooctene |
| TGF-β | transforming growth factor-β |
| TMJ-OA | temporomandibular joint osteoarthritis |
| UC-derived WJ | umbilical cord-derived Wharton’s Jelly |